Mainz Biomed N.V. (MYNZ)
Delisted
16 Mar 2026
NASDAQ (CM) NASDAQ (CM) Primary $
0. 70
-0.04
-5.0719%
$
2.86M Market Cap
- P/E Ratio
- Div Yield
21,831 Volume
-1.69 Eps
$ 0.74
Previous Close Investors:
Day Range
0.63 0.72
Year Range
0.55 5.34
Want to track MYNZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
2 Small-Cap Biotechs That Could Reward Patient Investors
Speculative investors and patience rarely go hand in hand. Nevertheless, if you're looking to invest in the small-cap biotech sector, patience is a requirement.
Marketbeat | 6 months ago
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed N.V. MYNZ announced a 1-for-40 reverse stock split, effective Dec. 3.
Benzinga | 1 year ago
